Telatinib in Combination With Capecitabine/ Oxaliplatin in 1st Line Gastric or GEJ Cancer

NCT03817411 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

90

Enrollment

INDUSTRY

Sponsor class

Conditions

Gastric Cancer

Interventions

DRUG: Telatinib
DRUG: Capecitabine
DRUG: Oxaliplatin
DRUG: Placebos

Sponsor

Taizhou EOC Pharma Co., Ltd.

Collaborators

[object Object]
[object Object]